Mode
Text Size
Log in / Sign up
N/A N=100 Supportive Care

Investigation of Patient Benefits With a New Supporting Ostomy Product in Patients With a Newly Stoma Formation

Stoma Ileostomy · Stoma Colostomy

Enrolled (actual)
100
Serious AEs
5.0%
Results posted
Aug 2024
Primary outcome: Primary: Number of Times With Stoma Effluent Leakage Outside the Baseplate (e.g. Onto Clothes or Bedsheets) Within the Last 2 Weeks — 1.57; 0.93 Number of leakages per two weeks — p=0.046

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Heylo (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Coloplast A/S
Primary completion
Aug 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Times With Stoma Effluent Leakage Outside the Baseplate (e.g. Onto Clothes or Bedsheets) Within the Last 2 Weeks
1.57; 0.93 0.046 sig
SECONDARY
Patient Self-management
68.201; 74.815 <0.001 sig
SECONDARY
Ostomy Leakage Impact Tool - 'Emotional Impact' Domain
57.124; 77.136 <0.001 sig
SECONDARY
Ostomy Leakage Impact Tool - 'Usual and Social Activities' Domain
82.750; 89.072 <0.001 sig
SECONDARY
Ostomy Leakage Impact Tool - 'Coping and in Control' Domain
62.779; 77.082 <0.001 sig
SECONDARY
Health Related Quality of Life
0.713; 0.747 0.075
SECONDARY
EQ-5D-5L Visual Analogue Scale (VAS)
71.771; 76.454 0.004 sig

Summary

People with intestinal stomas can have, despite development of better ostomy products, problems with leakage which influence their quality of life negatively. To overcome this, Coloplast has developed a new supporting ostomy product called Heylo™, which has an adhesive sensor layer that should be placed underneath the baseplate. The sensor layer consists of an electronic sensor system that continuously detects moisture and output leakage underneath the baseplate. A transmitter connected to the sensor layer continuously evaluates the incoming information and sends a status to a smartphone software application, which based on a predefined flow decides which information to deliver to the user about the baseplate status.

Eligibility Criteria

Inclusion Criteria

  • Have provide written informed consent.
  • Be at least 18 years of age and have full capacity.
  • Have had their stoma for less than 9 months.
  • Have intact skin on the peristomal area (assessed by investigator)
  • Be able to use one of the five test products (i.e. Ø40, Ø50, Ø60, Ø70, Ø80 mm)
  • Ileo- or colostomists with liquid and/or mushy output (Bristol scale type 5-7)
  • Is willing to refrain from use of paste and protective sheets.
  • Have a smartphone applicable for the HeyloTM app.
  • Have been self-managing stoma appliance for at least 14 days.
  • Are able to follow study procedures for 3 months (assessed by investigator)
  • Are willing to receive their ostomy products through Coloplast Charter for the duration of the study.

Exclusion Criteria

  • Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
  • Is breastfeeding.
  • Is pregnant based on urine pregnancy test.
  • Enrolled in another current research study or have previously participated in this investigation.
  • Has known hypersensitivity towards any of the products used in the investigation.
  • Is using/have a pacemaker.
  • Has a complicated stoma at baseline (dehiscence/prolapse/hernia)
  • Has limited life expectancy or receive palliative care.
  • Has stage 4 cancer.
  • Having more than one stoma synchronously
  • Having ongoing non-healed abdominal wounds
  • Reoperation / stoma reversal planned during the study period.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05135754). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search